In recent years, the exploration of alternative nanocarriers, including hydrogels, dendrimers, and micelles, for ocular drug delivery has broadened the scope of nanotechnology applications in the field of ophthalmology
Manassas, VA, USA) and were tested and authenticated by DNA typing at Shanghai Jiao Tong University Analysis Core (Shanghai, China)
By staying informed, regularly monitoring eye health, and working closely with a healthcare provider, the risks can be managed, ensuring that the benefits of these drugs outweigh the potential drawbacks
doi:10.1016/S0021-9258(18)33050-3
In addition, combining multiple diseases may reveal stronger associations, possibly due to shared pathological mechanisms or disease processes